Generic Name
Oxaprozin
Brand Names
Coxanto, Daypro
FDA approval date: October 29, 1992
Classification: Nonsteroidal Anti-inflammatory Drug
Form: Tablet, Capsule
What is Coxanto (Oxaprozin)?
Oxaprozin tablets are indicated: For relief of the signs and symptoms of osteoarthritis, For relief of the signs and symptoms of rheumatoid arthritis, For relief of the signs and symptoms of juvenile rheumatoid arthritis Oxaprozin tablets are a non-steroidal anti-inflammatory drug indicated for:, Relief of signs and symptoms of Osteoarthritis , Relief of signs and symptoms of Rheumatoid Arthritis , Relief of signs and symptoms of Juvenile Rheumatoid Arthritis
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment